The agriculture ministry will ask the Indian arm of Swiss agrochemical giant Syngenta to stop import and marketing of its flagship insecticide Emamectin Benzoate in India soon.
The ministry’s decision, once notified, will put curtains down on a four-year old tussle the company had been waging against the ministry after the latter framed charges against Syngenta for importing two consignments of the insecticide without valid approval from the registration committee of the Agriculture Ministry in 2007.
Syngenta had near monopoly on the sale of ‘Emamectin Benzoate 5%’ until domestic competitors began to sell low-cost versions of the product in the market in recent years. Industry pegged the Syngenta brand at worth Rs 100 crore.
A senior agriculture ministry official confirmed the development. He said Agriculture Minister Sharad Pawar had already cleared the order and the notification was expected after vetting by the law ministry soon.
Despite repeated attempts, Syngenta officials were not available for comments.
The company is known to have admitted the error by stating it had initiated the process of importing the product in the hope of receiving a registration certificate in due course. The registration committee had also found discrepancies in Syngenta’s declared and actual sources of import.
Incidentally, Syngenta had lost a legal battle over Emamectin Benzoate two years ago after it argued against the registration committee approval for a low-cost generic product manufactured by a North Indian pesticide firm.
The ministry action against Syngenta is for violating the provisions of Insecticides Act, 1968.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
